



IS IT FEASIBLE? SELF-AFFIRMATION FOR 
HEREDITARY BREAST AND OVARIAN CANCER GENETIC COUNSELING 
 
by 
Anna Kathryn Chassevent, BA 
 
 
A thesis submitted to Johns Hopkins University in conformity with the requirements for 










In recent years there has been increased understanding of the genetic 
factors that predispose people to cancer. While this increase in knowledge can 
improve patient health, patients, who are at increased risk for cancer, face 
decisions about testing, cancer screening, communication with family members, 
and even prophylactic surgery.  
Statement of problem:  
As more people face these decisions it is important for genetic counselors 
to support them in the decision-making process. Self-affirmation interventions 
may be an effective way to improve hereditary breast and ovarian cancer (HBOC) 
genetic counseling patient-centered outcomes. The study described is a 
randomized controlled trial to assess the feasibility of implementing a SA 
intervention in a cancer genetic counseling clinic. 
Methods:  
This study was conducted in a hereditary cancer clinic at St. Luke’s Health 
System in Kansas City, Missouri.  Patients who attended the clinic for a genetic 
counseling session, were randomized to completed a SA intervention or a control 
writing exercise beforehand and a survey of patient-centered outcomes afterward. 
Counselors completed a patient empowerment assessment after each appointment. 
The primary feasibility outcomes were patient acceptance of the SA intervention, 
patient attrition, and the effectiveness of the SA intervention. Secondary outcomes 
 
 iii 
were: decision self-efficacy, intentions to talk with family, genetic test uptake, 
patient empowerment, and HBOC knowledge. 
Results:  
All patient participants reported that the intervention did not interfere with their 
appointment (35/35). Coding analysis of patient essays showed that those who were in 
the intervention group were significantly more affirmed than those in the control group (p 
<= 0.01). None of the secondary outcomes were statistically significantly different 
between the control and intervention groups. Patient and counselor scores on the 
empowerment measure were not significantly correlated (p = 0.298). 
Conclusions:   
 Given our findings, follow-up studies, such as a phase II study is needed to 
enhance our understanding of SAs usefulness in buffering patients from the threat of 
cancer. Future studies should include more diverse populations and if SA is effective in 
the cancer setting, additional studies in other subspecialties of genetic counseling will be 
important prior to generalizing evidence across specialties.  
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Breast cancer is the most prevalent cancer in women, with 236,968 new 
diagnoses in 2014 alone (U.S. Cancer Statistics Working Group, 2016). In recent 
years there has been increased interest in understanding the environmental and, 
particularly, the genetic factors that predispose people to cancer. As a result, 
many genes have been identified that contribute to cancer predisposition. While 
this increase in knowledge can improve patient health, patients who have a 
genetically increased risk for cancer face difficult decisions about genetic testing, 
cancer screening, communication with family members, and even prophylactic 
surgery. As more people are faced with these decisions it is important for genetic 
counselors to enhance the process of patient decision-making.  
SELF-AFFIRMATION 
 Self-affirmation (SA) is a social science intervention that may be a novel way to 
improve patient decision-making and the genetic counseling process. SA theory is based 
on the concept that people work to maintain their perceptions of themselves as moral and 
consist persons, with high self-integrity (Sherman & Cohen, 2006; Steele, 1988). Self-
integrity is an individual’s perception of efficacy across multiple domains, defined further 
as their cumulative moral and adaptive adequacy or, maybe better understood, as their 
global self-efficacy (Steele, 1988). When people experience a threat to their self-integrity 
they naturally seek to neutralize the threat. The process of self-integrity protection can be 
best understood in context. For example, a woman may feel threatened by a negative 
health finding, but if she feels competent in her relationships and work, then her overall 
self-integrity is maintained and she can address the threat in a prudent and non-defensive 
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manner. On the other hand, when self-integrity is compromised, and other areas of self-
concept do not stabilize the threat, then individuals may defend themselves against the 
threating message to protect their self-integrity (Sherman & Cohen, 2006; Steele, 1988). 
For example, they may try to discredit or ignore a concerning message.  
 SA theory suggests that self-affirming people prior to facing a threat can reinforce 
their self-integrity and increase receptivity to the threatening message (Sherman & 
Cohen, 2006). Several SA techniques have been used in education and health 
communication research that have validated and shown promising effects of SA theory.  
HEREDITARY BREAST AND OVARIAN CANCER 
 Hereditary breast and ovarian cancer (HBOC) is one of the earliest identified, best 
understood, and the most prevalent cancer syndromes. It is estimated that 5-10% of 
women with breast cancer and 20% of women with ovarian cancer carry a gene variant 
that predisposes them to these cancers (Campeau et al., 2008; Walsh et al., 2011). HBOC 
can be caused by pathogenic variants in BRCA1 and BRCA2. Women with pathogenic 
variants in these genes have a lifetime risk of developing breast cancer between 40% and 
80%, with a lifetime risk for ovarian cancer between 11% and 40% (Petrucelli et al., 
2013). In addition to BRCA1 and BRCA2, multiple other genes, including, PALB2, 
CHEK2, ATM, BRIP1, RAD51C, and RAD51D have been associated with hereditary 
breast and/or ovarian cancers, with varying levels of penetrance, each lower than BRCA1 
and BRCA2 (Walsh et al., 2011). Women are often identified to be at increased risk of 
HBOC based on their family or personal history of breast and ovarian cancers. These 
women are then referred for genetic counseling and offered genetic testing. Those who 
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have been diagnosed with HBOC have family planning, prophylactic surgery, screening, 
and a myriad of other medical and family communication decisions to make.  
GENETIC COUNSELING FOR HBOC 
 Often, communication about genetic risk, decision making, and treatment are 
guided by genetic counselors, who are experts at calculating genetic risk estimates, 
HBOC education, and counseling and facilitating patient-centered decision-making. With 
the growing number of genes associated with hereditary cancers, genetic counseling 
services are becoming more in-demand and counselors are having to see more clients in 
less time. Interventions before a counseling session may help to facilitate decision-
making and to shorten session length. In this study, we examine the feasibility of a pre-
session self-affirmation intervention aimed at facilitating patient empowerment, decision 
self-efficacy, and improving patient behavioral outcomes.  
CONCEPTUAL FRAMEWORK: THE EXTENDED PARALLEL PROCESS MODEL 
Outcomes for this study were informed by the Extended Parallel Process Model 
(EPPM). The EPPM is often used as a framework in communication and fear appraisal 
research. This model simplifies individuals’ responses to fear-inducing stimuli to two 
components: perceived threat and perceived efficacy. As shown in Figure 1, this theory 
states that when people are faced with a risk message, they process it by weighing their 
perceived efficacy against the perceived threat (Maloney, Lapinski, & Witte, 2011). 
Perceived efficacy is conceptualized as an individual’s beliefs about being able to avert 
the threat and overcome the situation. Perceived threat is conceptualized as the 
combination of individuals’ beliefs about how susceptible they are to the threat and how 
severe they believe the threat to be. Similar to SA theory, if individuals perceive that their 
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efficacy to manage a threat is sufficient, then they accept the risk message and engage in 
protection motivation to reduce the risk of the threat. If instead, individuals perceive that 
the threat is greater than their efficacy to manage it, then they engage in a defensive 
motivation and attempt to minimize or discredit the threatening message. The EPPM has 
been used extensively to inform fear and risk control communication studies and aligns 
with the SA model (Maloney, Lapinski, & Witte, 2011). A study by Napper, Harris and 
Klein (2014) showed that the SA process moderates the variables in the EPPM. They also 
found that including SA in the EPPM increases the model’s explained variance. 




Genetic counseling sessions are often focused on genetic risk and susceptibility 
information. Therefore, it is possible that clients who perceive this information to be 
threatening may defend themselves against the information in genetic counseling sessions 
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to minimize the perceived threat. Reinforcing a client’s sense of self before a genetic 
counseling appointment may promote information acceptance and communication within 
the session.  
PRIMARY OUTCOMES BACKROUND: FEASIBILITY 
 To our knowledge no research has examined the impact of a SA intervention in 
genetic counseling (Etchegary & Perrier, 2007). There is one study that assessed the link 
between spontaneous SA and genetic risk information seeking. This study of 594 
participants in the ClinSeq cohort found that those who were higher in spontaneous self-
affirmation were more likely to seek out genetic risk information despite being high in 
anticipated affect (Ferrer et al., 2014). Anticipated affect is a correlate for worry. These 
results suggest the value of further research. 
 Given the lack of intervention research in this context it is important to conduct a 
feasibility study (phase I) prior to a full-scale (phase II) intervention study to assess: 
favorable outcomes, clients’ reactions to the SA intervention, and the logistics of and 
barriers to SA implementation. Feasibility research studies generally have smaller sample 
sizes and therefore statistically significant outcomes are not expected. These studies 
allow for exploration of many aspects of implementation and preliminary outcomes. The 
National Cancer Institute has recognized the need for more intervention-based feasibility 
studies prior to full-scale studies to determine “whether comprehensive and multilevel 
evaluations are justified (Bowen et al., 2009, p. 1).” A feasibility study of SA in genetic 
counseling would allow for preliminary examination of the impact of SA on genetic 
counseling outcomes to provide estimates of effect size and, consequently, the necessary 
sample size for a future study. 
 
 6 
SECONDARY OUTCOMES BACKGROUND  
 Based on what we know about genetic counseling for HBOC, the EPPM and self-
affirmation theory, a SA intervention may be anticipated to increase patient behavioral 
intentions to minimize the threat of HBOC cancer and acceptance of threatening 
messages about their cancer risk. The field of genetic counseling has outlined acquisition 
of knowledge, psychosocial support, facilitating family communication, and aiding in 
decision making as goals for patient encounters (Bernhardt, Biesecker, & Mastromarino, 
2000). Combining our study model and genetic counseling goals for this study, we chose 
to measure post-visit knowledge, decisional-efficacy, empowerment, genetic test 
intentions, screening intention, and intentions to talk with family about cancer risk as 
outcomes of a self-affirmation intervention.  Figure 2 shows how the selected outcomes 
fit within the EPPM.  
Figure 2. Conceptual framework based on Extended Parallel Process Model 





Self-Efficacy and Empowerment 
 Based on the EPPM and the literature, SA has the potential to improve patient 
self-efficacy and empowerment. At this time only one study has addressed implementing 
SA specifically in a medical encounter. This randomized controlled trial of SA in 99 
African American patients with hypertension found that the SA treatment group 
requested and provided more information about their medical condition from their 
primary care provider in a medical encounter (Havranek et al., 2012). Recordings of the 
patient-provider interactions were assessed using Roter Interaction Analysis System 
(RIAS) coding. In the SA group, the patient-provider communication was characterized 
as being more interested, friendly, responsive, interactive, and respectful. These results 
give evidence that patients may be more engaged in a genetic counseling conversation 
and have higher decision-making efficacy after a SA exercise.  
Behavior Intentions  
Research in SA suggests that SA may increase patients intentions to pursue 
testing and intentions to talk with family. Behavior intentions following genetic 
counseling are particularly important since they A study of 84 participants assessing 
message degradation and behavior intentions found that patients who were self-affirmed 
and were at risk for type II diabetes were more likely to intend to pursue online type II 
diabetes risk information (van Koningsbruggn & Das, 2009). Additionally, they were less 
likely to affirm the statements: “The message was exaggerated,” “The message was too 
extreme,” and ‘The message was distorted” in relation to a health message about type II 
diabetes risk. This indicates that those at increased risk of diabetes were more accepting 
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of the threatening message and more likely to intend to seek out their risk information. 
These effects were not found in the low-risk group. 
Taber et al.’s (2014) work with the ClinSeq cohort found that patients lower in 
spontaneous SA and higher avoidance tendencies showed lower intentions to learn a 
genetic testing result (p = 0.001). Furthermore, they found that participants who were also 
high in avoidance tendencies but instead higher in spontaneous self-affirmation had lower 
information avoidance (p < 0.001).  
Ferrer et al.’s (2015) work with the same cohort found that those who were higher 
in spontaneous affirmation were significantly more likely to intend to share actionable 
results (p = 0.05) and non-actionable results (p = 0.01) with family members. Although 
spontaneous SA is distinct from prompted SA, this finding could suggest that an 
intervention would also increase discussions with family members. Additionally, SA 
interventions have been shown to significantly increase participants’ feelings of love and 
connectedness to others compared to a control group, which may also be related to 
intentions to talk with family (Crocker, Niiya, & Mischkowski, 2008).  
Knowledge  
 Several studies have shown that SA increases patients’ decisions to seek out 
threatening information regarding their health; demonstrating a greater openness to the 
threatening message. A study of 40 university students found that those who were self-
affirmed were more likely to choose to receive risk results for a hypothetical condition 
than those who were not affirmed (p < 0.01) (Howell & Shepperd, 2012). This study was 
repeated and validated by Howell & Shepperd (2017) in two follow-up studies.  
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 In one study 66 women were given an article to read stating that coffee 
consumption increases the risk for fibrocystic breast disease half of the women were 
given a self-affirmation exercise focusing on kindness before reading the article (Reed & 
Aspinwall, 1998). Those who drank coffee and were self-affirmed oriented to and 
accepted risk confirming information significantly more quickly than did coffee drinkers 
who were un-affirmed. Other studies have shown similar results related to accepting 
threatening health messages (Harris & Epton, 2009). As previously mentioned, specific to 
genetic information, findings from the ClinSeq cohort found that those who were higher 
in spontaneous self-affirmation were more likely to report seeking out genetic risk 
information despite being high in anticipated affect (Ferrer et al., 2014). Since SA can 
increase message acceptance and motivation to avoid the threat, it is consistent that 
clients may attend to the threatening message more carefully and remember information 
about HBOC more accurately (Harris & Epton, 2009).   
INTERVENTION RESEARCH  
Intervention research in genetic counseling is in its infancy. The majority of 
intervention research in genetic counseling compares information delivery models, such 
as online, tele-counseling, and in-person models (Athens, et al., 2017). A systematic 
review of randomized control studies in genetic counseling found only 27 articles 
between 1990 and 2015 that assessed ‘enhancements’ to genetic counseling practice. The 
type of enhancements varied widely, including decision aids, genetic counseling as an 
enhancement to standard care, adding a psychosocial element to genetic counseling 
through a social worker, culturally sensitive genetic counseling, personalized risk 
assessments, etc.  This review found that the intervention research had widely varying 
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degrees of rigger and quality, with a need for more systematic, quality research. The field 
of genetic counseling needs to establish a tradition of quality research that is based on the 
generations of work in education, patient care, and counseling. Quality feasibility studies 
can help to establish what intervention work from these fields are justifiable to invest 
resources for a fully powered study. The current study is a strong step towards evidence 
based practice in genetic counseling.  
SIGNIFICANCE  
Our study applies SA in a novel clinical setting, broadening the research 
trajectory in both SA and genetic counseling. SA interventions are simple, evidence 
based, and theory driven; when applied to HBOC genetic counseling they have the 
potential to easily and efficiently improve patient care. 
Objective  
The objective of this study is to investigate whether a self-affirmation intervention 
is feasible and demonstrates potential to be effective in the context of genetic counseling, 
therefore justifying a phase II study. 
Specific Aims 
1. To describe patients’ responses to a novel SA intervention, including perceived 
impact, barriers, and facilitators to implementing such an intervention on a wider 
scale  
2. To assess the implementation of a SA intervention in a genetic counseling clinic 
based on:  




b. If the SA intervention is effective in affirming HBOC genetic counseling 
clients 
3. To assess the preliminary impact of a SA intervention by comparing outcomes 
between SA and control condition participants. Specifically assessing:  
a. Behavioral outcomes: Intentions to talk with family, test uptake, intentions 
for follow-up mammograms 
b. Psychosocial outcomes: Empowerment, decision self-efficacy 
c. Knowledge outcomes: HBOC knowledge 
METHODS  
STUDY DESIGN 
This research is an intervention-based, randomized controlled, feasibility study. 
HBOC genetic counseling patients received the short State-Trait Anxiety Inventory 
(STAI) and either a SA intervention or control writing exercise before their appointment 
and after their appointment completed a survey assessing the study outcome measures. 
Genetic counselors completed a post-appointment survey regarding the patient’s 
empowerment, after each appointment with a patient participant.  
STUDY SAMPLE  
The inclusion criteria for this study was: female patients, 18 years of age or older, 
competent to read and write in English, and had first time genetic counseling appointment 
at Saint Luke’s Health System’s Cancer Institute in Kansas City, Missouri. Patients were 
eligible if they had prior genetic testing through another clinic. Participant selection was 
indiscriminant of whether patients had cancer or a history of cancer. For patients who do 
not have cancer, genetic counseling was scheduled based on family history of specific 
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cancers or self-referral for cancer risk. Patients were ineligible if they were being seen for 
follow-up appointments in the clinic because they already had a relationship with the 
genetic counselor.  
Power Analysis: For a fully powered study assessing the effect of SA on genetic 
counseling outcomes, we estimated that we would have needed 296 participants to 
identify a small to medium effect (Cohen’s d = 0.35) with beta of 0.85 and alpha of 0.05 
(Sweeney & Moyer, 2015). To assess feasibility outcomes, we recruited 35 patients and 2 
genetic counselor participants. Between 24-50 participants are needed for a feasibility 
study that aims to estimate a standard deviation and calculate sample size for a phase II 
study. For a more detailed discussion on these estimates see Sim & Lewis, 2012 and 
Julious, 2005.  
Genetic counselor participants were the two genetic counselors employed at Saint 
Luke’s Health System (WF, KW). They self-selected for participation after seeing an 
invitation to host the study on the National Society of Genetic Counselors Cancer Special 
Interest Group webpage. 
PROCEDURES  
Patient Consent 
The scheduling coordinator at Saint Luke’s Health System identified participants 
from the referral list who met the study criteria. When calling to schedule patients’ 
appointments the coordinator asked participants if they would be interested in having a 
researcher contact them about participating in a study related to their genetic counseling 
appointment. If they consented to have their contact information shared with the research 
 
 13 
team, the scheduling coordinator gave the agreeing potential participants’ names, phone 
numbers, and appointment date to the student investigator (AKC). About one week prior 
to their appointment the student investigator called potential participants and obtained 
verbal informed consent (See Oral Consent Script for Client Participants in Appendix A). 
The student investigator left a maximum of three voicemails with the potential participant 
over a three-business day period. If the investigator was unable to contact the potential 
participant, they were considered lost to follow-up. Patients who consented to participate 
were randomly assigned to complete the SA intervention or control condition, by flipping 
a coin. After consenting, the student investigator notified the clinic scheduling 
coordinator which patients consented to participate. Oral consent was approved by the 
presiding IRB.  
Intervention and Post-Appointment Survey Procedure 
When patient participants checked in for their genetic counseling appointment, 
they were given the STAI and the SA or control writing exercise. These documents were 
self-administered by the patient in the waiting room directly before their genetic 
counseling appointment.  
 Genetic counselors were blinded to the study condition of the patients who 
participated. Counseling sessions proceeded per protocol for the clinic. As patients left 
their appointment, they received a paper survey regarding their demographic information 
(age, sex, education, race, ethnicity, cancer status), experience in the study, decision self-
efficacy, empowerment, HBOC knowledge, intentions to talk with family, mammogram 
screening intentions, and intentions to pursue genetic testing. They were also given the 
option to access an electronic version of the survey. Patients who chose the electronic 
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version were emailed a link to the survey by the student investigator (AKC). Hard copy 
surveys were returned to the front desk. Electronic versions were completed via an online 
survey program. A week after their appointment, all patients who had not completed the 
in-person survey received an electronic reminder notification to complete the online 
questionnaire. The clinic coordinator sent the intervention/control, in-person post-
surveys, and counselor surveys to the NIH by standard mail. Upon completion of the 
online survey or paper questionnaire participants were mailed a $15 gift card.  
Counselor Post-Appointment Survey 
After each appointment with a study participant, genetic counselors completed a 
short patient empowerment survey in their office. Upon completion of the study Saint 
Luke’s Health System genetic counselors were given a $1,400 gift card as a recruitment 
incentive.  
 All procedures were approved by the National Institutes of Health review board.  
STUDY INSTRUMENTS 
Intervention  
For the SA intervention, participants were asked to rank 11 items (artistic skills, 
athletics, business/money, creativity, independence, music, politics, relationships with 
friends and family, religious values, sense of humor, spontaneity) from most important to 
least important (See Appendix B) (Creswell et al., 2013; Havranek et al., 2012). They 
were then asked to write about the item that is most important to them, why it was 
important to them, and how they have used it recently. The control group ranked the 
same list and wrote about their 9th ranked item and why it might be important to someone 
else.  Both groups then ranked how important the value that they wrote about was to them 
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on a scale of 1-7. The intervention and control conditions were consistent with the 
exercises used in many other SA intervention studies (Creswell et al., 2013; Havranek et 
al., 2012; Ferrer, Klein, & Graff, 2017).  
Immediately after the intervention or control condition, participants completed the 
2-minute short version of the State-Trait Anxiety Inventory (Marteau & Bekker, 1992). 
This measurement entails six questions to assess the participant's current state of anxiety. 
The purpose of the STAI was to identify if those who were more anxious were more 
affected by the SA intervention. The intervention and STAI were designed to take about 
10-15 minutes together, we did not collect data on how long it took patients to complete 
the exercise. At the end of the intervention there was a detachable page asking for the 
participant’s email address to send them the post-intervention survey and a reminder to 
complete it.  
Patient Post-Intervention Survey 
 Patient post-appointment survey consisted of questions related to response to and 
acceptance of the SA measure as well as each outcome category (test uptake, intentions 
for screening, empowerment, intention to talk with family, decision self-efficacy, and 
HBOC knowledge). The survey was designed to take less than 15 min for participants to 
complete, data on how long participants spent on this measure was not collected in the 
clinic but was on the online version.  
 Response to SA measure. The patient response measure asked both open-ended and 
yes/no questions regarding patients’ acceptance of and response to the intervention or 
control. There was also a single question asking if and how patients thought that the 
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measure affected their counseling session to identify any overt interference of the writing 
exercise with their session. 
Decision self-efficacy. To measure decision self-efficacy, we used the Decision 
Self-Efficacy Scale (O’Connor, 1995). We chose this scale because it correlates with both 
decision conflict focusing on feeling informed and supported (r = 0.55), and knowledge (r 
= 0.61). Cronbach alpha ranges between 0.86-0.92 for this measure (Cranney et al., 2002; 
O’Connor, 1995).  
Test uptake.  For this section, we asked two questions to assess uptake; “Did your 
counselor offer you genetic testing in your counseling appointment?” (yes/no) and “If 
yes, do you plan to have genetic testing?” (yes/maybe/no).  
Intention to talk with family. Intention to talk with family was measured using 
two original questions. The first is a question that asked patients to select the categorical 
description of the family group they were most likely to share information with from a 
list of options, such as “I plan to talk to only a few people who are closest to me.” The 
second question which stated, “How likely are you to share results with the relatives you 
selected?” was rated on a 1-7 likert scale labeled “extremely likely” to “extremely 
unlikely.”  
Empowerment. Empowerment was assessed using the validated Genetic 
Counseling Outcomes Survey (GCOS-24) (McAllister et al, 2011). The GCOS-24 is a 
24-item instrument that was designed to measure positive outcomes of genetic 
counseling. Empowerment in this survey is conceptualized to include decisional control, 
cognitive control, behavioral control, emotional regulation, and hope. The scale has seven 
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dimensions, which exist under a single higher order construct. Internal consistency for 
this measure is 0.87 (McAllister et al, 2011).  
Patient Knowledge. Patient knowledge was measured using modified questions 
based on the National Center for Human Genome Research Knowledge scale and genome 
sequencing knowledge items from Kaphingst and colleagues’ study of informed consent 
(Kaphingst et al., 2012; Scherr, Christie, & Vadaparampil, 2015). These questions 
focused on patient’s broad knowledge needed to make an informed decision, rather than 
specific details, since counseling sessions may differ depending on a patient’s indication 
for HBOC genetic counseling.  Cronbach alpha for the original National Center for 
Human Genome Research Knowledge measure is 0.74, although this cannot be applied to 
our measure because of the modifications based the cancer clinical setting (Lerman et al., 
1996).  
Counselor After Visit Survey  
The counselor after visit survey consisted of a counselor version of the Genetic 
Counseling Outcome Scale (GCOS-24). This scale was modified from the original 
GCOS-24 for use by counselors and parallels the patient version. This measure consists 
of 24 likert scale questions that assess counselor’s perceptions of the patient’s 
empowerment. To create this measure, the student investigator (AKC) modified the 
original GCOS-24 to reflect third person language regarding the patient. This measure 
was then reviewed by researcher BB. The student investigator and BB discussed the edits 
and refined them for the final version.  It was designed to take 3-5 minutes for the 
counselors to complete after each session with a participating patient.  
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DATA ANALYSIS  
Data were analyzed using SPSS 25.0. The primary outcome variables were related 
to the feasibility of the SA intervention in the cancer genetic counseling setting and 
secondary outcome variable related to limited efficacy testing.  
Primary Outcomes 
Feasibility outcomes were measured in both the intervention and control groups. 
Because the writing exercise was universally well received by patients, we did not 
analyze the data for differences in responses between groups.  
To assess patients’ responses to the intervention, we analyzed their answers to the 
feasibility focused questions in section five of the post-visit survey. This section 
consisted of three yes/no and three short answer questions. The yes/no questions are 
reported as percentage of clients who indicated yes. Only a few patients responded to the 
short answer questions, therefore the answers were not coded for themes. For patients 
who responded, their comments are reported in full. Patient recruitment is reported as 
percentages of eligible clients who completed each step of the study and the reason for 
attrition, when known.  
Based on previous research by Ferrer et al. (2012) and Harris & Napper (2005), 
the self-affirmation essays were analyzed in several steps. The SA prompt asked patients 
to write about why the value that they chose was important to them and to give examples 
of how they used that value in their everyday lives. The student investigator (AKC) and a 
research trainee coded the essays for analysis. Individual statements were coded as either 
relating to importance, life application, or neither. The word count for statements 
regarding importance and life application were recorded, as well as total word count of 
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the essay. When the importance and life application categories appeared to overlap, they 
were differentiated by the mention of specific aspects of everyday life being coded in the 
latter category (i.e. “my husband makes me laugh during hard times”) and more general 
statements of importance in the former category (i.e. “friends are important because they 
have helped me through tough times”). Statements relaying that the value was important 
(e.g. “music is important to me”) or that described the value (e.g. “music and creativity 
go hand in hand for me”) were not included in the word count for either subcategory.  
Attitude strength for the essays was evaluated by rating how important the value 
selected appeared to be for participants on a 7-point Likert scale ranging from “not at all” 
to “very.”  
SA was assessed according to the raters answering the question, “setting aside 
your own opinions and values, how self-affirmed would you estimate the writer of this 
passage to have been (at the end)?” using a 5-point rating scale. A score of one was given 
if the essay mentioned the value but did not include: a description of how it applied to 
themselves, an elaboration about the importance of the value, or examples about how the 
writer upheld the value in her daily life. A score of five was given if the essay included 
an elaboration of why the value was important to the writer and several examples of how 
the writer upheld the value in her daily life. Scores between 2-4 were given based on 
amount of description about the importance of the value, application of the value to self, 
and number of examples. These designations were based on previous methods by Ferrer 
et al. (2012). Finally, any inclusion of statements about cancer, medical care, health, or 
their condition were noted to determine if patients were affirming on the same value as 
the cancer health threat.  
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Before analyzing the essays, the student investigator and a research trainee met to 
discuss the coding protocol. They each coded 10 essays independently, reviewed their 
codes together, and refined the coding criteria. They next coded 10 more essays and again 
discussed and refined the coding criteria. They then recoded the initial 10 essays 
independently to improve consistency. Interrater reliability for phrases discussing the 
importance of the value was 0.88, for phrases discussing examples of using the value was 
0.98, for attitude strength was 0.96, and for SA score was 0.94. The rest of the 24 essays 
were analyzed only by the student investigator (AKC). Intervention/control group 
labeling was removed from the essay transcripts for analysis. Although, as standard for 
the SA intervention, those in the control group were instructed to write about others and 
the intervention group were instructed to write about themselves therefore, for some 
essays, group participation was identifiable. While we recognize this as a limitation, it is 
consistent with other SA research and inherent to the fidelity of the intervention; if 




Analysis of secondary outcome variables included a comparison between 
treatment and control groups of test uptake, intentions for screening, empowerment, 
intention to talk with family, decision self-efficacy, and HBOC knowledge in order to 
identify variables that would be worthwhile to include in a phase II study (See patient 
survey, Appendix C). Analysis of these variables was also used to determine the 
necessary sample size to adequately power a phase II study. Secondary outcomes were 
compared using linear regression. A linear regression was conducted for each secondary 
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outcome, where group (intervention or control) was the independent variable and the 
secondary outcome was the dependent variable. Education, race, and anxiety score were 
entered into the model as additional predictor variables. All variables with the exception 
of cancer status, were treated as continuous variables. Cancer status was analyzed as a 
dichotomous variable. Any differences between intervention/control groups that resulted 
in a p-value  0.05 were considered statistically significant.  
Patient empowerment was also analyzed, comparing the total score for patients and 
counselors using a paired-samples t-test (See section 3 of patient survey of appendix C 
and appendix D). The difference between control and intervention group regarding the 
correlation between paired patient/client surveys was not analyzed. Effect sizes and 
standard deviations for each outcome were identified, and an estimated sample size for a 
fully powered study was estimated based on the power calculations. 
RESULTS 
RESPONSE RATE 
 When asked by the clinic coordinator, 82 patients consented to be contacted by the 
student investigator (AKC). The student investigator made contact with 64 of the 82 
patients, 18 were unable to be reached after 3-5 calls (a maximum of three voice 
messages). Sixty-two patients consented by phone. Only one patient declined consenting 
after completing the consent process. Another patient reported that she was unwell and 
asked not to finish the consent process. Additionally, two patients chose not to participate 
after they arrived in clinic. Of these, one was concerned that having had previous genetic 
counseling may affect our study and removed herself from participation. The other 
patient did not give a reason for declining participation. Fifteen patients, who consented, 
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were either late to their appointment or did not receive the intervention for other reasons, 
primarily related to clinic flow. Forty-four patients completed the writing exercise; one 
incorrectly completed the SA intervention and her data was removed from the study. 
Nine patients did not complete the post-appointment survey in the office or after 
receiving two reminder emails for the online post-survey. The attrition rate for the 
intervention group was 17.4% and 20.0% in the control group. Attrition rates did not 
differ significantly between groups (p = 0.647).  
Figure 3: Flow Chart of Participants 
 
 
Thirty-five patients completed all study procedures and were included in all 
statistical analyses. The counselors completed 45 post appointment surveys, which were 
included for analysis of the counselor version of the empowerment survey. Counselor 
surveys that did not have a matched patient empowerment survey were not included in 
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the patient/counselor empowerment correlation analysis. Of patients who agreed to be 
called by the student investigator (AKC) for consent 42.7% completed all study 
procedures. The scheduling coordinator at Saint Luke’s estimated that half of patients 
who were asked if they would agree to be contacted for consent agreed to be contacted, 
but this was not quantified for the study. Participant demographics can be found in Table 
1. No patients identified as Hispanic and 33 of 35 patients were offered genetic testing by 
counselors. 
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n = 16 (100%) 
n = 16 (84.21%) 
n = 32 
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American  
n = 0 (0%) 
n = 2 (10.53%) 
n = 2 
Other  
 
n = 0 
n = 1(5.26%) 
n = 1 
Total 
 
n = 16 
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High School  
n = 2 (12.5%) 
n = 3 (15.79%) 
n = 5 
Some College 
n = 6 (37.5%) 
n = 5 (26.32%) 
n = 11 
College Grad 
n = 2 (12.5%) 
n = 9 (47.37%) 
n = 11 
Grad school  
n = 6 (37.5%) 
n = 2 (10.53%)  










Not had cancer 
 
n = 12 (75%) 
n = 11 (57.89%)  
n = 23 
Have had 
cancer  
n = 4 (25%) 
n = 8 (42.11%) 
n = 12 
Total 
 
n = 16 
n = 19 









Several procedures were done to check the fidelity of the intervention. First, 
patients were asked to rank the question “How important is this item to you?” a 7 point 
Likert scale ranging from “very important (1)” to “unimportant (7)”. The mean score for 
the control group was 4.60 (SD = 1.50). The highest ranking was 2 and the lowest 
ranking was 7. All participants in the intervention group ranked their value as 1, “very 
important.” Independent sample t-test analysis showed a statistically significant 
difference between means (p <= 0.01) in the control and intervention group, indicating 
that patients in the intervention group considered the value that they wrote about to be 
statistically significantly more important to them than those in the control group. 
Levine’s test for equality of variances was not met (p <= 0.01) therefore equal variances 
were not assumed for this analysis. The table below shows the distribution of values 




Table 2: Patient ranked values 
 
 
   
 We calculated the total word-count of patient SA essays, the word-count of 
sentences/phrases that discussed the importance of the value, and the word count-of 
sentence/phrases that discussed examples of how the value was used recently. In addition, 
we rated the patient’s attitude and affirmation strength demonstrated in their essays. 
There was a significant effect of the control/intervention condition on the total word-
count of patient essays (p= 0.005). Meaning that essays were significantly longer in the 
intervention than in the control group. Levene’s test of equality of variances was 
significant for this measure (p= 0.001), therefore equal variances were not assumed. 
There was not a statically significant effect of group on the word-count of patient’s 
comments about why their chosen value was important to them (p = 0.558). Meaning that 
Values in Essays 
Control (9th ranked value) Frequency  
   Artistic skills 6 
   Business/Money 4 
   Athletics  3 
   Music  3 
   Creativity 2 
   Humor  1 
   Spontaneity 1 
Intervention (1st ranked value) Frequency 
    Relationships with friends and family 11 
    Religious values 10 
    Creativity 1 
    Independence 1 
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patients in the intervention group did not write more about the importance of the chosen 
value than those in the control group. Lastly, there was a significant effect of group on 
the number of words patients wrote giving examples of how they used the value in 
everyday life (p = 0.001), equal variances were not assumed for this group.  
Attitude strength assessed how important a value was to patients based on their 
essay transcript. For this measure, the coders rated how important they perceived the 
value to be. There was a significant effect of group on importance ratings between the 
control and intervention group (p <= 0.01) and of group on self-affirmation ratings (p <= 
0.01). 






p-value  Levene’s test 
Total Word 
Count 
26.20 words 56.96 words p = 0.005 p = 0.001 
Important Word 
Count 
11.40 words 13.41 words p = 0.558 * 
Example Word 
Count 
3.78 words 32.48 words p = 0.001 p <= 0.01 
Attitude 
Strength  
2.28/7 5.41/7 p <= 0.01 * 
Self-Affirmation 
Score  
1.65/5 3.72/5 p <= 0.01 * 





We were concerned about patients affirming on the same construct as the 
hereditary cancer threat and therefore noted any direct reference to patient’s diagnosis, 
family history, health, cancer, or medical care in their essays (Sivanathan et al., 2008). 
Three patients mentioned their health stating: 
“Before my cancer diagnosis, I prayed for three things- two of which were 
granted (my sister to have a life- saving operation and my dog to get over a 
debilitating disease). My third prayer/request was to not have cancer —two out of 
three wasn’t bad for me (intervention, 71, breast cancer).”  
“I left care at ---- (hospital) to see Dr. P---- because I was thinking 
creatively (intervention, 71, cancer).”  
“I have MS. I have been blessed to always be able to maintain my 
independence for the past 29 years following my diagnosis (intervention, 68, no 
cancer).” 
PATIENT-REPORTED FEASIBILITY  
Patients reported their response to the intervention based on six short answer and 
yes/no responses questions. All patients who did the post-test questionnaire said that they 
were able to finish the SA exercise. All patients said that the SA exercise did not affect 
their visit. All patients also said that the SA exercise did not hinder their visit. Nine 
participants reported that the SA intervention improved their appointment. Interestingly, 
two of those who said that the exercise improved their appointment were in the control 
group.  
Six participants responded to the short answer section of the surveys. Their 
answers can be found in Table 4. Although, there was not enough data to code the 
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transcripts, the patients in the control condition seemed to find the exercise to be 
irrelevant and annoying, while those in the intervention group seemed accepting and 
comfortable with the exercise. 
Table 4: Patient short answer response to intervention 
 
Group Quote 
Control It didn’t seem relevant, but (I) expect it 
was helpful or necessary for some reason 
unknown to me.  
Control  It seemed very random and not at all 
related. Honestly, I found it more 
annoying than anything.  
Control Not sure how the writing activity related 
to my appointment. I enjoyed the activity, 
thought, as it made me think.  
Intervention  I had no qualms about completing the 
writing activity as I feel comfortable 
writing in a narrative form and do not 
have a problem putting my feelings in 
writing  
Intervention I thought it was a little odd ~ but all in the 
name of research! My answers came 
easily to me - no problem! 
Intervention I felt this was a good idea in that 
Counselor knows your thoughts on 
participating in genetic testing, good or 
bad! 
 
Nine patients completed the study post-assessment online. Patients who took the 
survey online took an average of 10 minutes (max time 22 minutes; minimum time 4 
minutes) to complete it, which was within the expected time. Time to complete the post-
test was not measured for patients who completed it in the clinic.  
 
 29 
SECONDARY ANALYSIS   
Analysis of secondary patient outcomes included 16 patients in the control group 
and 19 patients in the intervention group. All regression analysis controlled for education, 
race, and anxiety scores unless otherwise indicated.  
Intentions to Talk to Family 
Intentions to talk to family was scored by ranking patients answers from 1-6 
based on the degree of family members who they intended to tell about their genetic 
testing results. The mean score for those in the control group was 4.62 (SD = 1.36) and 
4.89 (SD = 1.37) for those in the intervention group. Regression analysis did not show a 
significant effect of group on intentions to talk with family (p = 0.150). Of the 35 total 
participants, 18 indicated that they planned to talk to almost all of their family members, 
two indicated that they planned to talk to almost all their first and second-degree relatives 
who are at risk for cancer, nine indicated that they planned to talk to most of their first 
and second-degree relatives who are at risk for cancer, five indicated that they planned to 
talk with some family members, and two indicated that they planned to talk to a few 
people who were closest to them.  
Genetic Testing Intentions  
Patient-reported genetic testing intentions were scored on a scale of 1-3. A score 
of one indicated that they declined testing, two indicated that they may get testing, and 
three indicated that they would get testing. Patients in the control group had a mean score 
of 2.86. Two patients were not offered testing and one patient declined testing. Patients in 
the intervention group had a mean score of 2.67. Two patients in this group said that they 
may get testing, two patients declined testing, and one patient was not offered testing 
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based on her family/medical history. Linear regression of testing intentions between the 
intervention and control group indicated no significant difference between groups based 
on testing intentions (p = 0.191). 
Intentions for Follow-Up Mammograms 
Analysis of intentions to follow up with regular mammograms was rated on a 
Likert scale of 1 to 7 with the 1 being extremely unlikely and 7 being extremely likely. 
The control group had a mean value of 6.93 (SD = 0.26). One participant selected six, 
one participant had a double mastectomy and declined to answer, and the remaining 
reported that they were extremely likely to get mammograms. The intervention group had 
a mean score of 6.78 (SD = 0.73). One participant in this group selected a six and another 
participant selected a four, one participant had a double mastectomy and declined to 
answer, and the remaining reported that they were extremely likely to get mammograms. 
Linear regression did not show a significant effect of group on intentions for follow-up 




Table 5: Descriptive statistics and regression for patient outcomes. 
 





Mean  N  SD  Mean  N  SD  p R R2 SEE 
Intentions to talk 
with family 
 
4.62 16 1.36 4.89 19 1.37 0.150 0.496 0.249 1.26 
Test uptake 
 




















6.93  15 0.73 6.78  18 0.26 0.900 0.187 0.035 0.584 
- Controlled for education, race, and anxiety  
HBOC Knowledge 
HBOC knowledge was scored by patients receiving one point for each correct 
answer and no points for an incorrect answer. The maximum score on the seven questions 
was seven. Patients in the control group had a mean score of 6.25 (SD = 0.93).  The mean 
score for the intervention group was 5.79 (SD = 0.85). Linear regression did not show a 
significant group effect on HBOC knowledge (p = 0.274) (r = 0.274, r2 = 0.075). 
Although not statistically significant, patients in the control group had higher raw mean 
scores on the HBOC knowledge measure. Eleven of 35 patients got all questions correct. 




Table 6: Number of correct and incorrect answers 
for patient knowledge scale 
 
Correct Incorrect Question 
35 0 All people who have an altered cancer gene will get cancer 
 
32 3 If an altered cancer gene is found, the related cancer can 
always be prevented or cured 
 
27 8 The sibling or child of someone with an altered cancer gene 
has a 50% risk of having the same altered gene 
 
34 1 A person whose genetic testing does not find an altered 
cancer gene can still get cancer 
 
32 3 People who have genetic testing will always get clear positive 
or negative results  
 
18 17 All people who have multiple family members with cancer 
qualify for genetic testing 
 
32 3 If someone has an altered cancer gene, screening and healthy 




Considering decisional self-efficacy, the control group had a mean score of 4.84 
(SD = 0.27) and the intervention group had a mean score of 4.95 (SD = 0.08). Linear 
regression showed no significant effect of group on decision self-efficacy (p = 0.732) (r = 
0.284 and r2 = 0.081). Across both groups scores on this measure were high, 23 of 35 
participants (65.7%) selected 5/5 on all questions. The average rating across questions for 
all participants was 4.90/5.  
Empowerment 
Analysis of patient completed GCOS-24 surveys showed a mean score in the 
control group of 140.56 (SD = 16.33) and of 140.75 (SD = 15.51) in the intervention 
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group. Comparing the control and intervention group through linear regression did not 
show a statically significant effect of group on empowerment scores (p = 0.124, r= 0.450, 
r2 = 0.203).  
The counselor completed GCOS-24 empowerment measure showed that the 
control group had a mean score of 137.20 (SD = 14.51) and the intervention group had a 
mean score of 136.47 (SD = 12.30). Linear regression comparing counselor’s scores of 
patient empowerment did not show a significant effect of group (p-value of 0.577, r= 
0.294, r2 = 0.068). Although not statistically significant, this score was in the negative 
direction, indicating that the control group tended to have higher empowerment scores 
than the intervention group. More counselors completed the post survey than patients, 
with the sample size for the control group being 20 and 23 in the intervention group. 
The correlation between patient and counselor GCOS-24 was analyzed using 
paired differences between the patient and counselor surveys, which was not statistically 
(p = 0.298, R2 = 0.089). These results indicate that counselor’s interpretation of their 




Figure 4. Fit line of counselor by patient empowerment scores 
 
 
Effect Size and Sample Size for Phase II Study 
 We calculated the effect size for intentions to talk with family since it showed the 
greatest trend toward significance and did not display the ceiling effect that several of the 
other measures showed. The effect size for intentions to talk with family was 0.20, which 
corresponds with a small effect size (Cohen, 1992). To detect a statistically significant 
(alpha < 0.05) effect with based on this effect size a fully powered (beta = 0.85) study 
would need to have 477 participants. This is larger than the 296 participants we 
calculated prior to completing this study based on a small to medium effect (d = 0.35) 




The purpose of this study was to assess the feasibility of a SA intervention in a 
HBOC genetic counseling clinic. Secondarily, we aimed to assess whether a SA 
intervention affected patients’ behavioral intentions, knowledge, decision self-efficacy, 
and empowerment. SA has never been applied in a genetic counseling setting and 
intervention research in genetic counseling, as previously expounded on, is in its 
foundational stages. By addressing these questions, our research was relatively novel to 
both the arenas of genetic counseling and SA. Many studies have assessed SA in 
response to health messages but fewer have looked at SA applied in a clinical setting 
(Sweeney & Moyer, 2014; Havranek et al., 2012). SA has the potential to be a simple, 
easy to implement measure to improve genetic counseling outcomes and help patients to 
better access their own strengths (Crocker, Niiya, & Mischkowski, 2008; Cohen & 
Sherman, 2014).  
FEASIBILITY OF INTERVENTION 
When discussing feasibility research, it is important to keep the goals of this 
method of work at the forefront. In their discussion of feasibility studies, Bowen et al. 
(2009) outline the intentions of this work as assessing acceptability, implementation, 
practicality, expansion, integration, demand, adaptation, and/or limited-efficacy of an 
intervention. Often these outcomes do not clearly differentiate from each other so we will 
generally discuss how our study sheds light on each focus area. 
Acceptability measures how individuals involved in administering and completing 
the intervention respond to the intervention (Bowen et al., 2009). Patients in this study 
were open to completing the SA exercise. Several patients in the intervention group 
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commented that they found the control exercise irrelevant or annoying, while patients in 
the intervention group seemed much more accepting. Patients’ willingness to negatively 
comment in the control group, and the generally positive acceptance in the intervention 
group indicated that the intervention was a more acceptable exercise for patients. Patients 
also did not feel like the writing exercise interfered with or negatively impacted their 
appointment. The finding that the intervention was acceptable was consistent with prior 
studies of SA (Havranek et al., 2012; Sweeney & Moyer, 2014). Future work should 
assess the genetic counselors’ opinions and responses regarding the intervention.  
This study expanded research in self-affirmation beyond the populations 
previously studied. While there is abundant research regarding health messages and SA, 
to our knowledge only one other study has applied SA to a clinical setting. We 
demonstrated that the intervention was successful in affirming patients, and thus is worth 
pursuing in a phase II study in a genetic counseling setting. Doing so will broaden the 
application and understanding of SA theory. 
Implementation and practicality assess whether the intervention was both able to 
be implemented as is and if it could be adjusted based on the needs of the intervention 
site (Bowen et al., 2009). There are several ways that SA interventions could be 
implemented and adjusted for broader clinical use. The simplest adjustment for clinical 
use is the decision whether or not to administer the intervention. Our work showed that it 
was easy for the clinic administration to decide, based on clinic flow, if the patient should 
complete the intervention or proceed directly to their appointment. While it could be 
argued that non-implementation is a drawback to the intervention, when thinking about 
broader implementation in the future we suggest that it is a benefit. Our results showed 
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that the intervention did not add an extra burden to patients or the clinic by utilizing the 
time in the waiting room for implementation. This finding may make SA more appealing 
to busy clinical settings, so that it is accepted where it otherwise may not be.  
Because of its familial nature, we were concerned that patients who chose family 
and friends as their top value may self-affirm on the same construct as the threat of 
HBOC, which might minimize the effect of SA (Sivanathan et al., 2008). While three 
patients talked about their health in their essays, only one had chosen friends and family 
as their top value, therefore this interference was less of a factor than we anticipated 
although it should be considered in future work.  
Adaptation is closely related to implementation and practicality. Adaptation 
studies look at different ways of implementing an intervention - either to improve the 
intervention itself or to implement the intervention in a novel real-world context. There 
are many different styles of SA interventions beyond the ranking and essay method that 
we used in our study. The most relevant adaptation for a genetic counseling clinic would 
be to eliminate the writing demand on patients. There are several SA interventions that 
present participants with a series of scales based on their values, which other studies have 
shown to be effective in self-affirming participants (Steele & Liu, 1983; Napper, Harris, 
& Epton, 2009). A similar exercise as the written one used in this study could also be 
administered orally. We did not choose these alternatives because they require either 
digital implementation or a proctor. In their 2017 article, Cameron et al. called for self-
affirmation to be incorporated into the counseling session itself. A counseling method 
that incorporates principles of SA could be a promising path forward for SA in genetic 
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counseling, although attention would have to be paid to effects on the length of the 
session. 
 Integration assesses how systems need to change to implement the interventions 
broadly (Bowen et al., 2009). Given the ease of the SA intervention, the modifications 
that need to be made for an SA intervention to be more broadly implemented are 
relatively minimal. Some clinics have electronic check in, which could make SA more 
difficult to administer, but these kiosks could prompt patients to complete the 
intervention on screen, or could print the intervention for patients. One study used a cell 
phone, text message based self-affirmation intervention that could be used in a clinical 
setting where hard copy interventions were not possible (Arpan, Lee, & Wang, 2016). A 
text message intervention may not be beneficial for all populations because patients who 
were not familiar with texting or who had limited data plans may be less comfortable 
with this format.  
A more formidable constraint to broader implementation is the clinical demands 
that limit counselors from conducting research. Many counselors have a busy clinic 
schedule in addition to clinical documentation, mentoring students, teaching, and 
working on their own research. During our study design process, the study team 
contacted multiple clinics local to the research institution and posted an advertisement 
about study participation on the National Society of Genetic Counseling Cancer SIG 
group. The Saint Luke’s clinic genetic counselors were the only clinic who agreed to host 
the study at their site. This may indicate that in general counselors have clinic constraints 
that prohibit intervention research. Personal conversations by the student investigator 
with counselors indicated that many genetic counselors felt that there are significant 
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clinic limitations to intervention implementation. Work should be done in genetic 
counseling, beyond SA, to assess counselors’ interest in intervention adoption in their 
clinic. Given the importance of evidence-based practice in genetic counseling, we need to 
assess and move the field forward to identify and address these limitations. Twenty years 
ago, quality clinical intervention research was called for, saying,  
“The field should embrace data to document clients’ needs, how the counseling 
process functions, and behavioral outcomes, as well as to evaluate the 
effectiveness of various counseling interventions. Without this data, it is difficult 
for a profession to be convincing about its importance in health care delivery 
(Biesecker, 1998).”  
Although observational and information delivery methods (i.e. telegenetics, web-
based, or in-person) research has flourished, intervention research to improve genetic 
counseling sessions is still limited (Athens, et al., 2017).  
SECONDARY OUTCOMES – LIMITED EFFICACY TESTING 
Consistent with being a feasibility study, our study was underpowered to find 
statistically significant results for the secondary outcomes assessed. To inform which 
variables would be most appropriate for a phase II study, we analyzed behavioral 
intentions outcomes, knowledge, decision self-efficacy, and empowerment. The chosen 
outcomes endeavor to address a variety of different domains that have been identified as 
goals of genetic counseling, namely; behavioral change, information dissemination, 
decision-making, and psychosocial implications (Redlinger-Grosse et al., 2016; 
Bernhardt, Biesecker, & Mastromarino, 2000). Our findings have several implications 
both for a future phase II study and for continued research in genetic counseling.  
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Secondary Outcomes Significance 
 One of the most striking findings was that we did not see any trends towards 
significance in the secondary outcomes, and in fact, several of the raw score findings 
were in the opposite direction than expected. Scores on counselor empowerment, test 
uptake, HBOC knowledge, and mammogram intentions were all higher in the control 
group than the intervention group. None of these trends were statistically significant, but 
the change in direction of the outcomes prompt questions about the study design and 
effectiveness of the intervention in this population. We chose the outcomes based on past 
research in SA and the Extended Parallel Processing Model, which has previously 
successfully been applied to understand SA theory (Napper, Harris and Klein, 2014). 
There are several possible explanations for these inconsistent findings, which should be 
addressed in future research.  
 The small sample size undoubtedly explains our lack of significant findings but 
we anticipated that the data would begin to show trends toward significance. Rather we 
found that several of the raw scores were in the opposite direction than expected. One 
explanation could be that we may have sampled a portion of the population in the control 
group who, by chance, were higher on these outcomes. Additionally, given the ceiling 
effect that was seen for decision self-efficacy, mammogram intentions and test uptake, 
the intervention group may have had a few individuals who indicated below average 
answers without a balancing effect of higher scores limited by the ceiling. There is also 
the possibility that the intervention lessoned the social desirability bias and prompted 
people to more honestly report their intentions in the intervention group. This would have 
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given them lower scores in the intervention group but may suggest a positive effect of the 
intervention.   
Other explanations of our ambivalent results could be that patients either were not 
actually affirmed by the intervention or that SA was not effective for this setting or 
population. Through our analysis of patient essays, we found that patients in the 
intervention group were significantly more self-affirmed than those in the control group. 
Furthermore, the same, or a nearly identical, intervention has been used in a variety of 
other studies which had significant findings, so it is unlikely that the intervention itself 
was ineffective in affirming clients (Creswell et al., 2013; Harris & Napper, 2005; 
Havranek et al., 2012; Ferrer et al., 2012; Ferrer, Klein, & Graff, 2017). It is possible that 
while numerous studies have shown positive results for SA intervention, due to 
publication bias, the intervention may have been weaker than anticipated. In their meta-
analysis of 16 studies of SA and responses to health information Sweeney and Moyer 
(2014) used trim-and-fill analysis to account for publication bias. Even with this 
adjustment they maintained that SA was effective.  
Based on past research, it is more likely that our population was as not suited to 
gain a benefit from SA as we predicted. The theory of SA proposes that when faced with 
a significant threat, if self-integrity is weak, that people will defend themselves against 
the threatening message. Our population may not have seen the genetic counseling 
appointment or their risk of hereditary cancer as a significant threat. Half of our 
population had already had cancer and may have viewed genetic testing as an explanation 
for their cancer instead of a new vulnerability in their health. It is likely that these 
patients had already had many more threatening experiences throughout their treatment, 
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so genetic counseling added a negligible threat burden. Those who had not been 
diagnosed with cancer may have viewed genetic counseling as a way to reduce the 
ambiguity of their family history and get answers, which would reduce the threat rather 
than raise it. In our study, we attempted to control for threat by using the STAI to 
measure anxiety measure. It may have been more effective to directly ask questions about 
how threatened (worried) patients were by the genetic counseling appointment, the risk of 
a hereditary cancer, or having genetic testing.  
One factor that may also have affected our results was that our population was 
primarily white, well educated, and middle-aged. Other research has demonstrated that 
SA tends to be most effective for those who feel marginalized; another form of threat. 
Our patient participants may not have been threatened by the medical setting. A study of 
SA and college students’ grade point average (GPA) found that Latino students in the 
intervention group had a higher GPA after four semesters, while this effect was not 
shown in for White students (Brady et al., 2016). Another study showed that SA reduced 
the effect of stereotype threat against women on a cognitive task, while men (who were 
not stereotyped) showed no difference between control and intervention groups (Martens 
et al., 2006). Often, genetic counseling patients are more educated, have a higher social 
economic level, and are early adapters so they may not feel threatened by a genetic 
counseling appointment. As genetic counseling is expanding to more clinics and the 
general population SA may become more important (Lee et al., 2005).   
Considering both the findings from our study and other literature, it may be more 
effective to conduct a phase II study with African American, Latino, or other 
marginalized populations, where genetic counseling appointments may be more 
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threatening. Another consideration would be to do the study in a high risk maternal/fetal 
medicine clinic that sees a high proportion of patients with fetal anomalies. Many 
prenatal genetic counseling clinics see a large proportion of patients who are advanced 
maternal age or have other indications that confer a relatively minimal risk to their 
pregnancy, and these patients should not be included in a phase II study. We did not 
choose a high-risk prenatal population because of the difficulty of consenting patients 
who are in crisis after hearing of a likely fetal anomaly. It may be worth designing a 
study to reach this population because of the substantial threat these patients face, the 
diverse patient population, and because the majority of the decisions in prenatal genetic 
counseling are values based decisions. In prenatal genetics, unlike in HBOC genetic 
counseling, there are few treatment guidelines so the decision to continue or terminate the 
pregnancy is based on the patient’s values.  
Another consideration for a phase II study in a high risk prenatal population is 
that we are not aware of any research in SA that has been administered in a population in 
a crisis situation as would be encountered by high-risk prenatal patients. Other research 
has shown that anger and negative affect eliminate the positive influence of SA (Ferrer et 
al., 2012; Ferrer, Klein, & Graff, 2017). A recent study looked at the effect of affect on 
SA and behavioral change. In the study, 448 female participants who drank more than 
five drinks per week were induced either to be angry, fearful, or neutral (Ferrer, Klein, & 
Graff, 2017). They were then self-affirmed or not through a writing exercise and then 
given an article linking alcohol consumption and breast cancer. Interestingly, although 
SA significantly improved intentions in other groups, those who were angry and self-
affirmed showed a trend towards being less likely to change their behavior then those 
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who were not affirmed (p = 0.069). This finding was reported after our study was 
conducted and measures of positive or negative emotions were not included in the present 
research, but future research should be designed with attention to patient affect.  
Figure 5. Differences in behavior change intentions between affirmed and 
unaffirmed women who drink 5 alcoholic beverages a week induced to be fearful, 
angry, or neutral (Ferrer, Klein, & Graff, 2017). 
 
It is uncertain how the affect surrounding the threat of having a severely disabled 
fetus would influence the effect of SA. SA theory would suggest that higher anxiety 
should make SA more beneficial, but given the other findings regarding affect the sudden 
extreme situation of a prenatal fetal diagnosis may have unexpected results.   
Lastly, it could be argued that our findings, which are contrary to the expected 
outcome, bring into question the necessity and practicality of a larger study given the 
limited resources for research. Based on our data, we would still conclude that a phase II 
study that integrates changes based on our findings would be worth pursuing.  We found 
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that the intervention was well accepted, easy to implement, and there are many questions 
for further analysis that could identify how to best use SA in a clinic. Furthermore, given 
the significant research giving credence to SA, we would suggest that a phase II study 
would be important to perform.  
Intentions to Talk with Family 
While there were not significant differences between the treatment and 
intervention groups, patients reported very high intentions to talk with their family 
compared with previous studies. Eighty-three percent of participants said that they 
intended to tell at least their immediate family members about their genetic testing. This 
is substantially higher than other literature, which has shown that patients who receive 
genetic counseling inform only 15–20% of their family members about their risk 
(Hodgson et al., 2016).  In a study of 63 patients with breast or ovarian cancer at risk for 
HBOC, 89% said that they were against notifying distant relatives about their diagnosis 
of cancer and 30% were against informing close relatives of their diagnosis (Claes et al., 
2003).  It is unclear why our population seems more willing to share this information 
with their family than in previous research. It is possible that as more people become 
aware of genetic testing and genetic predisposition to cancers that conversations with 
family are easier and happen more frequently than previous research has shown. Recent 
research has shown that 78% of patients told their first-degree relatives about their cancer 
risk (Daly et al., 2016). While this a promising change it needs to be confirmed in 
continued research and in other at-risk relatives.  
 
Genetic Testing and Follow-Up Screening Intentions 
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As predicted, uptake of genetic testing and mammogram screening intentions 
were high for our population and demonstrated a ceiling effect. Our findings were 
consistent with past literature. One study of 302 clients eligible for BRCA1/2 testing 
found that 90% of clients chose to get genetic testing (Butrick et al., 2014). In the current 
study 84% of patients decided in favor of testing and 91% of patients said that they were 
extremely likely to get regular mammograms. While not significant, those in the 
intervention group had lower intentions on both variables, which may represent patients 
being more resistant to social desirability bias and more honestly reporting their 
intentions. We are interested to see if this trend continues in a larger study or if it 
occurred by chance. 
HBOC Knowledge  
The knowledge survey was designed to contain basic knowledge that all patients 
should know when leaving their genetic counseling appointment in order to make an 
informed decision about testing or to accurately convey information to family members. 
With this in mind, the survey was designed so that patients would be able to answer all 
questions correctly after genetic counseling. Patient scores in our study were similar to 
those found from the basic knowledge scales that were used to formulate the scale for this 
study (Kaphingst et al., 2012; Scherr, Christie, & Vadaparampil, 2015).  
There were a few findings on the knowledge scale that were particularly 
concerning. First, almost half (48.6%) of participants said that all people with a family 
history of cancer qualify for testing, when in fact there are many that cancers do not 
indicate a genetic predisposition or where the related gene is still unknown. 
Misunderstanding this concept is unlikely to negatively affect a patient’s health but it 
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may be concerning for the field of genetic counseling. If many patients believe that they 
have a right to testing, it undermines the need for a qualified professional such as a 
genetic counselor to differentiate between those who need testing and those who do not 
qualify. If patients are indiscriminately tested it could result in negative patient outcomes 
and a financial burden for patients and payers.  
Three patients (8.6%) said that if a hereditary determinant for cancer is found that 
the related cancer can always be prevented or cured and three patients (8.6%) said that if 
a damaged cancer gene is found then behavior change and screening will not help to 
prevent the related cancer. Both of these results indicate concerning beliefs that could 
either lead to unrealistic treatment expectations or fatalism, which could be detrimental to 
a patient’s medical care. These results in addition to other research showing that genetic 
counseling appointments are information heavy (Roter et al., 2006; Roter et al., 2009), 
may indicate that too much information is being given in genetic counseling 
appointments so that the most important information is getting lost. These findings need 
to be investigated in a broader patient population.   
Decision Self-Efficacy  
The majority of patients rated themselves very high on decision self-efficacy 
(mean = 4.9/5). While our study only involved two counselors, this finding may validate 
the value of genetic counseling in HBOC patient care. A pre/post genetic counseling 
decision self-efficacy study could identify if patients are generally high in self-efficacy 
related to genetic decision-making or if the counseling session was effective in increasing 
decision self-efficacy.  Because of the observed ceiling effect, we would not recommend 
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including decision self-efficacy in a follow-up SA study. Another consideration is that 
our results were related to the decision self-efficacy measurement and not necessarily 
high decision self-efficacy in patients. While other studies have found greater variation 
on the same decision self-efficacy measure (Hall, Bernhardt, & Dodd, 2015; Bunn & 
O'Connor, 1996), ours is not the first study to observe similar ceiling effects. In their 
study assessing a decision aid for women choosing osteoporosis treatment, Cranney et al. 
(2002) found that both pre- and post- intervention the women where high in decision self-
efficacy by this measure.  
We chose this measure because it assessed both decision self-efficacy and 
efficacy in the relationship between the patient and the genetic counselor. Our intention 
was to measure the interaction between the patient and counselor but in a phase II study 
we would recommend coding audio recordings of sessions using the Roter Interaction 
Analysis System (RIAS) to measure patient-provider communication outcomes. 
Havranek et al., (2012) previously effectively applied RIAS in their study of SA with 
African American patients with hypertension. RIAS has previously been used to analyze 
patient-provider communication in HBOC genetic counseling appointments (Dijkstra et 
al., 2013; Ellington et al., 2005) 
Empowerment  
The GCOS-24 empowerment measure is a combined measure of decisional 
control, cognitive control, behavioral control, emotion regulation, and hope (McAllister 
et al, 2011). Generally, this measure can be looked at as a patient's ability to manage and 
interpret the impact of the genetic condition in their family. Compared with other 
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research using the GCOS-24 patients in our study scored slightly higher than other 
patients who have taken this measure (McAllister et al, 2011; Inglis et al., 2015).  
Remarkably, patient and counselor scores were not significantly correlated (p = 
0.298, R2 = 0.089). While this could be an effect of our small sample size, it is 
concerning that counselors may not be able to accurately identify patient’s self-efficacy. 
It would be interesting in a larger study if these results remain consistent. With more 
patients, it would be beneficial to assess those pairs who are most discordant and if there 
are distinguishing patient characteristics that precipitate counselors incorrectly assessing 
patient empowerment 
CLINICAL IMPLICATIONS 
 Given that the data did not identify significant secondary outcomes, there are 
limited clinical applications of our work at this time. As outlined there are many 
questions to pursue in continued clinical research. If there were significant results in a 
larger study then self-affirmation interventions could be implemented before a genetic 
counseling appointment. Cameron et. al., (2017) suggest that counselors could 
incorporate values reflections into the genetic counseling appointment to decrease 
defensiveness. Ideally more research will be done to develop and implement self-
affirmation as a freeform intervention within the counseling session. SA research could 
also be expanded to develop a general counseling method to help people to spontaneously 
self-affirm (Ferrer et al., 2014).   
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STUDY LIMITATIONS  
 This study had many limitations consistent with other feasibility work, but also 
had several specific limitations. The most prominent limitations are related to the sample. 
The sample size was comparable to many feasibility studies, but was not powered to 
identify statistically significant secondary outcomes. Also, the sample comprised fewer 
than 30% of patients who were seen in the Saint Luke’s genetic counseling clinic during 
the recruitment period. Since we were not able to access patient information for those 
who did not consent to participate, we do not know if there were differences between 
those who participated in the study and those who did not. While the sample 
demonstrated a range in age, cancer status, and education, there were only two 
participants who identified as African American and one as native American; the 
remainder identified as White. According to census bureau data from 2015, 55% of 
residents in Kansas City, MO identified as White, 29.6% as Black, 9.7% as Hispanic and 
2.85% as Asian. Even accounting for genetic counseling generally having a higher 
proportion of White patients, our population was skewed (U.S. Census Bureau, 2015).  
  Another limitation was that we chose to implement the anxiety measure after the 
intervention. Although this was done intentionally, so that the anxiety measure did not 
influence the intervention, it likely jeopardized the use of anxiety as a control. In future 
research, we would recommend a short survey that askes about patients’ worries 
regarding the genetic counseling session to be completed before the SA measure.  
CONCLUSIONS  
 Overall, the results of this study demonstrate that a phase II study of SA in genetic 
counseling is worth pursuing. While the secondary outcomes were not statistically 
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significant they suggested many questions that warrant follow-up assessment. A phase II 
study should include several modifications to the current design. It should not measure 
decision self-efficacy, but could warrant analysis of audio recordings of the genetic 
counseling appointments using RIAS, similarly to Havranek et al.’s (2012) work 
assessing differences in patient-provider communication using a SA intervention for 
racially discordant medical hypertension appointments. Additionally, there should be 
research into developing counseling techniques for incorporating SA into counseling 
practice. Beyond SA, there should be more research related to genetic counselor 
acceptance of research and interventions to improve their practice processes.  
 This study is a valuable step towards more intervention research related to genetic 
counseling processes and methods. We hope that research investigating adaptations of 
proven interventions in the fields of social science, counseling, and education will 
continue in genetic counseling. While genetic counselors have much to offer, we are a 
young profession and would greatly benefit from drawing on others’ experiences, 




APPENDIX A: CONSENT FOR PARTICIPATION 
ORAL CONSENT SCRIPT FOR CLIENT PARTICIPANTS  
 
Study Title:  Is it Feasible?: Self-Affirmation for Hereditary Breast and Ovarian 
Cancer Genetic Counseling 
 
Principal Investigator:  Lori Erby  
 
 [Greeting].  Hi, my name is Anna Chassevent, I am a researcher at the National Institutes 
of Health. I’m calling because you have an appointment at the High-Risk Breast Cancer 
clinic at St. Luke’s Health System, and I think you may be eligible for a project I am 
doing. Is now a good time for you to talk or is there a better time for me to call back? 
(either continues or sets up time to call back).  
 
Thank you. For this project, we are studying a way to improve your genetic counseling 
experience.  We are working to see if a short writing exercise before your appointment 
can help improve the conversation and content in our genetic counseling appointments. 
You do not have to join, it is your choice. Would you be interested in hearing more about 
the study?  
 
If you say yes, we will ask you to arrive 15 minutes early to your appointment and fill out 
a survey and a short writing exercise about things that are important to you. After your 
appointment, we will ask you to complete a follow-up survey either in the office or 
online. If to be completed online, we will give you the link to access the survey. It will 
take 10-15 minutes for the first survey and exercise and about 10-15 min for the follow-
up survey. You may feel uncomfortable answering some of the questions. You can skip 
any question that you do not want to answer and you may stop at any time.  We will 
collect your answers and use them to see if the writing exercise improves clients’ 
experience. There will also be several questions about how you felt about the writing 
exercise. These will help us to know if other clients would be accepting of it in the future.  
 
There is a risk that someone outside the study will see your information. We will do our 
best to keep your information safe by keeping your information on a secure computer. 
We will not record your name. Instead, we will ask you to create code words, when we 
share your information with other researchers, we will ask them to use the same 
protections.  If you are pregnant, there are no additional risks to your fetus from 
participation in this study.  
 
You may benefit from this study by having a better genetic counseling experience. We 
will use the answers to the questions to see if clients are accepting of the exercise and if it 
improves clients’ genetic counseling experience.  We will not give you the results of the 
study unless you are interested and contact us for results.  We will let the research 




As another option, you do not have to participate in this study. If you decide not to 
participate in the study, then your genetic counseling care will not change in any way 
from normal client care. If you change your mind about participating in the study, then 
you can stop being in the study at any time.  
 
If you complete all parts of the study, we will give you a $15 gift card to thank you for 
participating.  
 
Do you have any questions?  You may contact the primary researcher on this study, Lori 
Erby at (301) 443-2635, about any further questions or problems with this work. 
 
Would you like to join the study? 
 
If yes, please arrive 15 minutes early to your appointment and the study representative 
will give you the first survey when you arrive.  
 
The National Institutes of Health reviews NIH staff researchers at least yearly for 
conflicts of interest.   I can give you a link that contains details about this process. Would 
you like this link? (if yes: http://ethics.od.nih.gov/forms/Protocol-Review-Guide.pdf).  
You may ask your research team for additional information or a copy of the Guide. 
 
If you agree to the terms of the study and are willing to participate, you may proceed to 
verbally consent. Your consent means that you have been informed of the study’s 
purpose, its procedures, and the possible risks and benefits. Your consent means that you 
have been given a chance to ask questions before you consent. Your consent means that 
you have voluntarily agreed to be in this study. If you are willing to participate, please 
verbally consent now. 
 
Researchers Contact Information: 
Anna K. Chassevent BA             Lori Erby, ScM, CGC, PhD 
Associate Investigator              Principal Investigator, NHGRI 
Genetic Counseling Graduate Student           Director, JHU/NHGRI 
JHU/NHGRI Genetic Counseling Program           Genetic Counseling Training Program 





WRITTEN CONSENT FOR GENETIC COUNSELOR PARTICIPANTS  
 
              DEPARTMENT OF HEALTH & HUMAN SERVICES       Public Health Service 
            
    
Study Title:  Is it Feasible?: Self-Affirmation for Hereditary Breast and Ovarian 
Cancer Genetic Counseling 
 
Principal Investigator:  Barbara Biesecker 
 
Dear Genetic Counselor, 
You are invited to participate in a study conducted by researchers at the National 
Institutes of Health. 
 
Why is this study being done? 
This study has two main goals. First, to learn more about the acceptability of a self-
affirmation intervention to clients and counselors. Second, to understand what outcomes 
are most important for follow-up research using self-affirmation in a genetic counseling 
setting.  
 
Who can take part in this study? 
You must be a genetic counselor who sees hereditary breast and ovarian cancer clients at 
one of our partner hospitals.  
 
What is involved in this study? 
Some of your clients will be invited to enroll in the study.  They will be asked to 
complete a brief intervention or control prior to your visit.  You will then be asked to 
complete a brief (2-5 min) survey after each client who is participating in the study about 
the client’s engagement in the session.   We plan to enroll 35-40 clients at your site.  You 
will also be asked to complete a 10-15 min survey at the end of the study about your 
opinions on the intervention.  
 
What are the risks of the study? 
There are no known risks of taking part in this study. You may choose not to fill out any 
survey question. The after-visit surveys will take a few minutes after the appointment, 
which could increase stress on a busy day.  
 
Are there benefits to taking part in the study? 
You will not personally receive any benefits from taking part in this study.  We hope to 
learn more about if self-affirmation improves client communication and if it is acceptable 
to clients and genetic counselors.  
 
Social and Behavioral Research Branch 
National Human Genome Research Institute 
National Institutes of Health 
31 Center Drive (31/B1B36) – MSC 2073 
Bethesda, MD 20892-2030 
(301) 443-0283 - ph, (301) 480-5008 - fax 
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Do I have to participate? 
No, you do not have to take part in this study if you do not want to.  
 
Will I be compensated for participating?  
Yes, you will receive a $1,400 gift card.  
 
Who else will know that I am in the study?   
The counselors in this study will work closely with the research team. Clients who are 
involved in the study will also know that you are participating in the research protocol. 
Any published information will not identify the counselors involved in the research 
protocol.  
 
How do I participate? 
You can participate by completing this form and the subsequent questionnaires.  
Thank you for your interest and time!   
The National Institutes of Health reviews NIH staff researchers at least yearly for 
conflicts of interest.  The following link contains details on this process: 
http://ethics.od.nih.gov/forms/Protocol-Review-Guide.pdf.  You may ask your research 
team for additional information or a copy of the Guide. 
 
If you agree to the terms of the study and are willing to participate, you may proceed sign 
below. Your consent means that you have been informed of the study’s purpose, its 
procedures, and the possible risks and benefits. Your consent means that you have been 
given a chance to ask questions before you consent. Your consent means that you have 
voluntarily agreed to be in this study. If you are willing to participate, please sign below. 
 
I have read the explanation about this study and have been given the opportunity to 
discuss it and to ask questions.  I hereby consent to take part in this study. 
 
             
  
Signature of Genetic Counselor       Date 
 
           
Print Name 
 
Researchers Contact Information: 
Anna K. Chassevent BS          Barbara Biesecker, MS, CGC, PhD 
Associate Investigator           Principal Investigator, NHGRI 
Genetic Counseling Graduate Student        Director, JHU/NHGRI 
JHU/NHGRI Genetic Counseling Program        Genetic Counseling Training Program 











Thank you for participating in this joint research project between the NIH and St. Luke’s 
Health System. We appreciate your time and thoughtful participation. Please complete 
the following activity and survey. Give this packet to your genetic counselor during your 
appointment today.  
 
 
For this study to remain anonymous you will be asked to develop a code word. We will 
need to analyze all your documents together and the code word will allow us to assemble 
them. The code word will be created by combining the name of the first street that you 
grew up on with the name of your first pet. For example: Elm-mojo. If you do not have a 
pet, you can choose another name that is easy to remember (not your own). It is best for 
the code-word to be easy to remember because you will be asked for the same code-word 
to label your after-appointment survey.  
 
 





Values Writing Activity A:  
Code word (First street you grew up on + first pets name ex. Elm-mojo):________________ 
Rank the following items in the chart from 1-11 by what is most important to you. 1 being most 
important.   
Rank (1-11) Item 
 Artistic skills 
 Athletics  





 Relationships with friends and family 
 Religious values 
 Sense of humor 
 Spontaneity 
 
From the list above choose the item that is most important to you. Write about why it is important 
to you and how you have used it in everyday life, if possible, describing specific occasions on 
which this item determined what you did (use other reverse side for more space). 








How important is this item to you?  
1 2 3 4 5 6 7  








A number of statements which people have used to describe themselves are given below. Read 
each statement and then circle the most appropriate number to the right of the statement to 
indicate how you feel right now, at this moment. There are no right or wrong answers. Do not 
spend too much time on any one statement but give the answer which seems to describe your 
present feelings best.  
 
     Not at all  Somewhat Moderately Very much  
1. I feel calm         1          2         3          4 
2. I am tense         1          2         3          4 
3. I feel upset         1          2         3          4 
 4. I am relaxed         1          2         3          4 
5. I feel content        1          2         3          4 






Code word (First street you grew up on + first pets name ex. Elm-mojo):________________ 
Values Writing Activity B:  
Rank the following items in the chart from 1-11 by what is most important to you. 1 being most 
important.   
Rank (1-11) Value 
 Artistic skills 
 Athletics  





 Relationships with friends and family 
 Religious values 
 Sense of humor 
 Spontaneity 
 
From the list above select your 9th most important item. Write a few sentences about why it is 










How important is this item to you?  
1 2 3 4 5 6 7  




Code word _______________________ 
Self-evaluation questionnaire 
 
A number of statements which people have used to describe themselves are given below. Read 
each statement and then circle the most appropriate number to the right of the statement o indicate 
how you feel right now, at this moment. There are no right or wrong answers. Do not spend too 
much time on any one statement but give the answer which seems to describe your present 
feelings best.  
 
     Not at all  Somewhat Moderately Very much  
1. I feel calm         1          2         3          4 
2. I am tense         1          2         3          4 
3. I feel upset         1          2         3          4 
 4. I am relaxed         1          2         3          4 
5. I feel content        1          2         3          4 






APPENDIX C: CLIENT SURVEY 
 
Email Address Request 
 








Code word (First street you grew up on + first pets name ex. Elm-mojo):________________ 
Please provide the following demographic data about yourself  
 
Gender   ⁪ Male     Age _______ 
  ⁪ Female 
 
Racial Background (Please check all that apply) ⁪ American Indian or Alaska Native 
      ⁪ Asian or Pacific Islander 
      ⁪ Black  
      ⁪ White 
      ⁪ Other: ___________ 
Ethnic Background ⁪ Hispanic origin 
  ⁪ Not of Hispanic origin 
 
Education  ⁪  Some high school 
   ⁪  High school graduate 
   ⁪  Some college  
   ⁪  College graduate  
   ⁪  Graduate School  
 
Have you been diagnosed with cancer?  
Yes    No     Cancer type? ______________________ 
 
If yes, when were you diagnosed? ________ 
 
Section 1: 
Circle or check mark the selection that is most true for you 
 
Did your counselor offer you genetic testing in your counseling appointment?  
Yes   No, I did not qualify based on my cancer risk 
 
If yes, do you plan to have genetic testing? 
⁪ Yes    ⁪ Not offered 
⁪ Maybe  ⁪ I already have my genetic testing results 
⁪ No     
 
Was this appointment to receive genetic testing results?  
Yes            No 
 
How likely are you to get regular mammograms?  
1 2 3 4 5 6 7  




Which best describes your plans to talk with your family members about genetic testing results 
(check the one answer that is most true for you)?  
 
⁪   I don’t plan to talk to anyone. 
⁪   I plan to talk to only a few people who are closest to me. 
⁪   I plan to talk to some of my family members 
⁪   I plan to talk to most of my first and second-degree relatives who are at risk for cancer 
(children, brothers and sisters, parents, grandparents, aunts/uncles) 
⁪   I plan to talk to almost all my first and second-degree relatives who are at risk for cancer 
(children, brothers and sisters, parents, grandparents, aunts/uncles) 
⁪   I plan to talk to almost all my family members 
 
How likely are you to share results with the relatives you selected? 
1 2 3 4 5 6 7  
Extremely unlikely       Extremely likely 
 
Section 2:  
Below are listed some items involved in making an informed choice about genetic testing. Please 
show how confident you feel in doing each by circling the number from 1 (not at all confident) to 
5 (very confident) for each item listed below. 
 
I feel confident that I can:  
 
1. Get the facts about the genetic testing choices available to me from my genetic counselor.   
  1 2 3 4 5 
Not at all confident     Very confident  
 
2. Get the facts about the benefits different choices related to my cancer risk  
1 2 3 4 5 
Not at all confident     Very confident  
 
3. Get the facts about the risks different choices related to my cancer risk 
1 2 3 4 5 
Not at all confident     Very confident  
 
4. Understand the information enough to be able to make a choice about genetic testing  
1 2 3 4 5 
Not at all confident     Very confident  
 
5. Ask questions of my genetic counselor without feeling dumb  
1 2 3 4 5 




6. Express my concerns about different choices to my genetic counselor  
1 2 3 4 5 
Not at all confident     Very confident  
 
7. Ask for advice from my genetic counselor about my cancer risk  
1 2 3 4 5 
Not at all confident     Very confident  
 
8. Figure out the choice that best suits me 
1 2 3 4 5 
Not at all confident     Very confident  
 
9. Handle unwanted pressure from others in making my choice  
1 2 3 4 5 
Not at all confident     Very confident  
 
10. Let the genetic counselor know what’s best for me 
1 2 3 4 5 
Not at all confident     Very confident  
 
11. Delay my decision if I feel I need more time  
1 2 3 4 5 
Not at all confident     Very confident  
 
12. Take actions that will help prevent or minimize my risk of cancer 
1 2 3 4 5 
Not at all confident     Very confident  
 
Section 3:  
Complete the following questions with what is most true for you.  
 
1. I am clear in my own mind why I am attending the clinical genetics service 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
2. I can explain what my hereditary cancer risk means to people in my family who may 
need to know 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
3. I understand the impact of my hereditary cancer risk on my child(ren)/any child I may 
have 
1  2 3 4 5 6  7  




4. When I think about the condition in my family, I get upset 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
5. I don’t know where to go to get the medical help I/my family need (s) 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
6. I can see that good things have come from having this condition in my family 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
7. I can control how this condition affects my family 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
8. I feel positive about the future 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
9. I am able to cope with having this cancer risk in my family 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
10. I don’t know what could be gained from each of the options available to me 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
11. The possibility of having an elevated cancer risk in my family makes me feel anxious 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
12. I don’t know if my cancer risk could affect my other relatives (brothers, sisters, aunts, 
uncles, cousins) 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
13. In relation to the cancer risk in my family, nothing I decide will change the future for 
my children/any children I might have 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
14. I understand the reasons why my doctor referred me to the clinical genetics service 
1  2 3 4 5 6  7  




15. I know how to get the non-medical help I/my family need(s) (e.g. educational, 
financial, social support) 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
16. I can explain what my cancer risk means to people in my family who may need to 
know 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
17. I don’t know what I can do to change how my cancer risk affects me/my children 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
18. I don’t know who else in my family might be at risk for familial cancer 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
19. I am hopeful that my children can look forward to a rewarding family life 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
20. I am able to make plans for the future 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
 
21. I feel guilty because I (might have) passed my cancer risk on to my children 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
22. I am powerless to do anything about the cancer risk in my family 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
23. I understand what concerns brought me to the clinical genetics service 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
24. I can make decisions about my cancer risk that may change my child(ren)’s future/the 
future of any child(ren) I may have 
1  2 3 4 5 6  7  






Circle the option that is most accurate regarding Hereditary Cancers:  
1. All people who have an altered cancer gene will get cancer 
True   False   
 
2. If an altered cancer gene is found, the related cancer can always be prevented or cured 
True   False   
 
3. The sibling or child of someone with an altered cancer gene has a 50% risk of having the 
same altered gene 
True   False   
 
4. A person who’s genetic testing does not find an altered cancer gene can still get cancer 
True   False   
 
5. People who have genetic testing will always get clear positive or negative results 
True   False   
 
6. All people who have multiple family members with cancer qualify for genetic testing 
True   False   
 
7. If someone has an altered cancer gene screening and healthy behaviors can reduce their 
risk of dying from cancer 
True   False   
 
Section 5:                                                                                                                                                                                                                                                                                                  
Regarding the writing activity that you completed prior to your genetic counseling visit, circle the 
selection that most aligns with your experience:  
 
1. Were you able to finish the values writing activity? 
 Yes  No 
 





2. The values writing activity affected my appointment? 
Yes  No 
 







3. The values writing activity improved my interaction with my genetic counselor  
Yes  No 
 
4. The values writing activity hindered with my interaction with my genetic counselor  















If you would like to receive a $15 gift card for your participation, please include your name and 
address here. This information will be kept separate from your study documents.  
 
      
 
      
 




APPENDIX D: GENETIC COUNSELOR AFTER VISIT SURVEY 
DATE: 
CLIENT CODE WORD:  
 
Complete the following questions regarding the client in your last counseling session.  
 
1. This client is clear in her own mind why she is attending the clinical genetics service 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
2. This client could explain what her cancer risk means to people in her family who may 
need to know 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
3. This client understands the impact of her cancer risk on her child(ren)/any child she 
may have 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
4. When this client thinks about the cancer risk in her family, she gets upset 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
5. This client doesn’t know where to go to get the medical help she/her family need(s) 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
6. This client can see that good things have come from having this condition in her family 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
7. This client feels that she can control how her cancer risk affects her family 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
8. This client feels positive about the future 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
9. This client is able to cope with having this condition in her family 
1  2 3 4 5 6  7  





10. This client doesn’t know what could be gained from each of the options available to 
her 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
11. The possibility of having an elevated cancer risk in her family makes this client feel 
anxious 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
12. This client doesn’t know if her cancer risk could affect her other relatives (brothers, 
sisters, aunts, uncles, cousins) 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
13. In relation to the cancer risk in her family, this client feels that nothing she decides 
will change the future for her children/any children she might have 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
14. This client understands the reasons why her doctor referred her to the clinical genetics 
service 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
15. This client knows how to get the non-medical help she/her family need(s) (e.g. 
educational, financial, social support) 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
16. This client can explain what her cancer risk means to people in her family who may 
need to know 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
17. This client doesn’t feel that she knows what she can do to change how her cancer risk 
affects her or her children 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
18. This client doesn’t know who else in her family might be at risk for familial cancer 
1  2 3 4 5 6  7  






19. This client is hopeful that her children can look forward to a rewarding family life 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
20. This client feels that she is able to make plans for the future 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
21. This client feels guilty because she (might have) passed this condition on to her 
children 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
22. This client feels powerless to do anything about the cancer risk in her family 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
23. This client understands what concerns brought her to the clinical genetics service 
1  2 3 4 5 6  7  
strongly disagree     strongly agree 
 
24. This client feels that she can make decisions about her cancer risk that may change 
her child(ren)’s future/the future of any child(ren) she may have 
1  2 3 4 5 6  7  
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Are you interested in participating in research to improve our genetic 
counseling appointments?  
 
Study Name:  Is it Feasible?: Self-Affirmation for Hereditary Breast and Ovarian 
Cancer Genetic Counseling 
 
Principal Investigator:  Lori Erby 
Anna Chassevent, a student working on this study, will call you in the next few days talk 
more about the study and confirm if you would like to participate. If you would not like 
to be contacted, please let the St. Luke’s clinic coordinator know or call Lori Erby at 
(301) 443-2635.  
 
Why is this study being done? 
For this project, we are studying a way to improve your genetic counseling experience.  
We are looking to see if a short writing exercise before your appointment can help 
improve the outcomes of genetic counseling appointments.  
 
Why was I asked to join this study?  
All female clients being seen in the St. Luke’s Health System Hereditary Breast and 
Ovarian Cancer clinic for genetic counseling are given the opportunity to participate in 
this study. This study is a collaboration between the genetic counselors at St. Luke’s 
Health System and researchers at the National Institutes of Health (NIH). 
 
What will I be asked to do? 
You will be asked to arrive 15 minutes early to your appointment to fill out a survey and 
a short writing exercise about things that are important to you. After your appointment, 
we will ask you to complete a follow-up survey either in the medical office or online. The 
survey should take 10-15 min. If to be completed online, we will give you the link to 
access the survey.  
 
What are the risks of the study? 
There are no health risks to participating in this study. There is a risk that someone 
outside the study will see your study information. We will do our best to keep your 
information safe by storing it on a secure computer. We will not record your name. 
Instead, we will ask you to create a code word. If we share your information with other 
Social and Behavioral Research Branch 
National Human Genome Research Institute 
National Institutes of Health 
31 Center Drive (31/B1B36) – MSC 2073 
Bethesda, MD 20892-2030 
(301) 443-0283 - ph, (301) 480-5008 - fax 
 
 74 
researchers, we will ask them to use the same protections.  If you are pregnant, there are 
no additional risks to your fetus from participation in this study.  
 
What are the benefits for this study?  
You may benefit from this study by having a better genetic counseling experience. We 
will not give you the results of the study unless you are interested and contact us for 
results.  We will let the research community know about the results of the study.  
 
Do I have to participate?  
You do not have to participate in this study. If you decide not to participate in the study, 
then your genetic counseling care will not change in any way from normal client care.  
 
Will I get anything for participating?  
If you complete all parts of the study, we will give you a $15 gift card to thank you for 
participating.  
 
What if I have more questions?   
We will call you in a few days to discuss this study. You may also contact the primary 
researcher on this study, Lori Erby at (301) 443-2635, about any further questions or 
problems with this work. 
 
The National Institutes of Health reviews NIH staff researchers at least yearly for 
conflicts of interest. For more information, you can go to: 
http://ethics.od.nih.gov/forms/Protocol-Review-Guide.pdf.  You may ask your research 
team for additional information or a copy of the guide. 
 
A member of the research team will call you in the next few days to answer any questions 
and receive your consent if you are interested in participating. Your consent means that 
you have been informed of the study’s purpose, its procedures, and the possible risks and 
benefits. Your consent means that you have been given a chance to ask questions before 
you consent. Your consent means that you have voluntarily agreed to be in this study. We 
look forward to talking with you.  
 
Researchers Contact Information: 
Anna K. Chassevent, BA             Lori Erby, ScM, CGC, PhD 
Associate Investigator              Principal Investigator, NHGRI 
Genetic Counseling Graduate Student           Director, JHU / NHGRI 
JHU/NHGRI Genetic Counseling Program           Genetic Counseling Training Program 







APPENDIX F: SELF-AFFIRMATION ESSAY TRANSCRIPTS 
Essay 1:  
My family and friends are the very most important thing in my life. I value relationships 
more than anything. Connecting with people on a personal level is what makes me smile, 
laugh and allows me to get through difficult times. For example, going through my 
divorce last year was miserable but friends and family helped me get through it.  
Essay 2:  
Creativity is important to others because it is how they can express emotions that are 
otherwise hard to express. Creativity can be expressed in a variety of ways through 
dance, painting, music etc. Creativity is a lot about creation of something deeply 
personal.  
Essay 3:  
Support from family and friends makes all of life better. My husband’s support has 
helped keep me positive through years of ups and downs. Friends are there for support 
and humor. I think relationships with friends and family are the basis of all of the other 
items in the list.  
Essay 4:   
Friends and family are my foundation in my life. They support me with all ups and 
downs in life. I learn from them as well as they learn from me.  
Essay 5:   
My religious values for me tie in directly to my relationship with friends and family. My 
best friends are those people at church and religious groups who have weather my storms 
with me, who accept me for who I am, and who have been there for me no matter what. 
On a more personal note, I have grown in my faith over the past 10 years and have 
become quite comfortable with turning things over to God and trying to see His way for 
me no matter what the situation. Before my cancer diagnosis, I prayed for three things- 
two of which were granted (my sister to have a life- saving operation and my dog to get 
over a debilitating disease). My third prayer/request was to not have cancer —two out of 
three wasn’t bad for me. I know that God is looking after me and will use me for a good 
purpose.  
Essay 6:   
I like to help to (acluny?) my granddaughter to draw and appreciate art.  
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Essay 7:   
My relationship with God is most important to me. I know that He has a plan and a 
purpose for my life! It is in that relationship and through His word that I find strength, 
value, purpose and comfort.  
Essay 8:  
My husband & son love to be physical and are athletic. They say it makes them feel 
better.  
Essay 9:  
Sense of humor (No other writing).  
Essay 10:   
Relationships w/ friends & family are THE most important. I have learned they are here 
for more than ever imagined. They are all part of my village and have played vital roles 
in who I am & in raising my children.  
Essay 11:   
Used in every aspect of my life getting closer to my faith, studying the word and striving 
to live as such is an everyday goal.  
Essay 12:   
Music is relaxing, enjoyable, and is important to your sanity. I enjoy all types of music, 
depending on my mood as to which type I listen to. 
Essay 13:  
 
Religious values (No other writing)   
 
Essay 14:  
Athletics, not my thing I don’t care for sport. But I don’t mind working out for myself.  
Essay 15:   






Essay 16:   
My prayers are important because I know God is already working on my day to help me 
through. My artistic skills is something that has been a part of my life since my 
grandmother taught me to sew at the age of 5.  
Essay 17:   
Relationships with my family and friends is most important because they are the people 
that make my life awesome.  
Essay 18:  
Relationships with friends and family (No other writing) 
Essay 19:  
Creativity is most important because it applies to every area of life, not just artistically 
but intellectually. If you are creative you can problem solve by thinking outside the box. I 
left care @ KUMC to see Dr. P---- because I was thinking creatively.  
Essay 20:  
My Catholic Faith has made me the independent, hopeful, joy filled person that I am 
today. It is because of my Faith that I was able to leave my family and abuse and venture 
of on my own. I knew I wouldn’t be alone and that God would place new safe people in 
my life who would be there as my new family. My Faith has allowed me to travel to 
various countries on mission trips and develop a desire to serve those in need. It is 
because of God that I have the trusting, honest relationships I have today. He brought the 
perfect role-models into my life and the reason I am forever grateful for His love.  
Essay 21:  
Artistic skills will be important to someone if it drives their daily life. If your job or 
mental well-being in positively impacted by improving or using these skills, their 
importance would be more significant.  
Essay 22: 
My relationship with my friends and family have always been so important to me ~ 
especially my family. At this stage of my life I feel truly blessed to still have both of my 
parents, a wonderful husband and one terrific, smart and kind college student. I often will 
go to different family members for advice and guidance on various things in my life. For 
example, I am very much a career woman and as different work opportunities have 
presented themselves, I will go to my dad who was very successful in business. He 
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always has a different perspective and helps me sort through things. I recently turned 
down a career move after a detailed conversation with my dad ~ and I’m glad I did 
because a better opportunity presented itself. I will discuss with my husband stress or 
anxiety about really anything ~ He knows me inside and out and is my best friend in the 
world. I laugh the most with my husband.        
Essay 23:  
Music is important to others because they may use it to express themselves.  
Essay 24:  
Religious values-having a moral compass/ guide and solid foundation of faith helps with 
any and everything in life  
Essay 25:  
Family is everything to me. I have lost most of my family so throughout my life I have 
considered many of my friends family. Family are the ones that are there for you no 
matter what. They know everything about you, the good, the bad the ugly, and they still 
love and support you.  
All I ever wanted to be was a mother and now that I have children they are my world. I 
would do anything for them. And luckily, they have grown up to love each other and are 
there for each other. Family is my number 1!  
Essay 26:  
Artistic skills may be important to someone if that is their livelihood.   
Essay 27: 
They are into design, appearance is important to them.  
Essay 28: 
My relationships with family and friends are the most important to me because things can 
go wrong unexpectedly but you can always count on them to have your back. No matter 
how stressful my day gets I know I can go home and they will be there to brighten my 
day. I know they are who will be there in my highest points and at my lowest points. 
They don’t care about my money or skill sets or any of that, they love me for who I am as 






My family is always 1st for me. I could have already planned something to do for a day, 
but if my kids call I’ll change it so I can go with them.  
I can sit in a room with family – sit back and watch them talking and laughing and all I 
can do is smile. Our Love and Friendship as a family is wonderful.  
Essay 30:  
Without friends and family, I would be lost and bored.  
Essay 31: 
Creativity is a skill that people bring to the table. Creativity is valued because it varies so 
much among people and can produce an immense amount of growth within organizations 
of any kind. Creativity brings solutions.  
Essay 32: 
From an early age, my religious values were something instilled in me by my parents, 
and then later on I adapted and adjusted my beliefs based on my outlook on life. I owe 
everything I have and I am due to my faith and religious beliefs. God has been a constant 
support system and someone to lean on. Every milestone in my life, I have used my faith 
to have faith in the journey (college, nursing school, CRNA school, and starting a family 
of my own) and not lean on my own understandings.  
Essay 33: 
My relationship w/Jesus Christ is the most important in my life, because w/o Him I 
would not have life. When I feel stressed or frustrated or upset, all I have to do is pray for 
help and guidance and I feel at peace.  
Essay 34: 
Money tends to be a symbol of success and happiness. Generally, speaking, business is 
what generates money. Someone else can easily identify with the amount of money 
earned/acquired. The more money, the better perceived someone may think they are. 
Conversely, the lack of money may cause someone else to feel inferior.  
Essay 35:  
God is my #1 priority I put him first in my everyday life. Church on TV every day. Pray 





Some people are artistic some are not. If they are good at it I’m sure it’s important to 
them. 
Essay 37: 
Independence is most important to me because I have MS. I have been blessed to always 
be able to maintain my independence for the past 29 years following my diagnosis. This 
allows me to do all the things I want to do, mainly volunteering and was able to continue 
to work until this past year doing what I love. … nursing!  
Essay 38:  
Business & money are the staples of life. Unless you’re born w/a silver spoon in your 
mouth you will need to work, make money & be involved in business. At this stage in my 
life in the “world of work” for me, has turned into opportunities of service. This could be 
true of more retired persons.  
Essay 39: 
Athletics and sports in general I believe is a way to bring people together and form 
common bonds, rivalries, inspire bonding, and pride. Performing in athletic activities also 
can be a moral boost, stress reliever and other arenas for a sense of accomplishment.   
Essay 40: 
Spontaneity is the spice of life. The world is ever changing and you must be willing to 
change with it or you will be left behind.  
Essay 41: 
Music: I don’t know. Perhaps it makes them feel good to listen to music, gives them 
enjoyment. Perhaps it helps them to relax.  
Essay 42: 
I teach business education. I want to teach teenagers how to be prepared for real world 
careers and financing. As an educator, budgeting effects my life personally. Knowing 
how to successfully manage your business and finances will reduce stress in your life! 
Essay 43:  
Money & Business are some peoples priority because they are driven to be successful in 
other peoples eyes. Money is a necessary item to live, but shouldn’t be a top priority.  
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Essay 44 (Removed from analysis): 
1. Friends & family is what I live for.  
2. My religion has helped me through hard times  
3. I have always fell independence to stand as women power very important to me.  
4. My job is very important to take care of bills 
5. Making someone smile or happy makes me smile  
6. Do art work feels good just don’t have enough time 
7. I work out every morning M-F to do my best is important  
8. Country music  
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